| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2021 ( Subtotal = -$271,854 ) |
| | 2021 | 2020 | BIODESY, INC. | 384 OYSTER POINT BLVD STE 8 | SOUTH SAN FRANCISCO | CA | 94080-1967 | SAN MATEO | USA | R43MH119906 | SHG based screening assay for detecting effectors of brain localized GPCRs that can be used to probe mental illness related phenotypes | 001 | 2 | NIH | 9/22/2021 | -$170,574 |
| | 2021 | 2020 | BIODESY, INC. | 384 OYSTER POINT BLVD STE 8 | SOUTH SAN FRANCISCO | CA | 94080-1967 | SAN MATEO | USA | R43MH119906 | SHG based screening assay for detecting effectors of brain localized GPCRs that can be used to probe mental illness related phenotypes | 000 | 2 | NIH | 8/9/2021 | $0 |
| | 2021 | 2019 | BIODESY, INC. | 384 OYSTER POINT BLVD STE 8 | SOUTH SAN FRANCISCO | CA | 94080-1967 | SAN MATEO | USA | R43TR002783 | High-throughput screening assay of GPCR drug candidates using second harmonic generation for direct detection of structural changes | 000 | 1 | NIH | 8/22/2021 | -$101,280 |
|
| Issue Date FY: 2020 ( Subtotal = $260,927 ) |
| | 2020 | 2020 | BIODESY, INC. | 170 HARBOR WAY STE 100 | SOUTH SAN FRANCISCO | CA | 94080-6102 | SAN MATEO | USA | R43MH119906 | SHG based screening assay for detecting effectors of brain localized GPCRs that can be used to probe mental illness related phenotypes | 000 | 2 | NIH | 5/18/2020 | $260,927 |
|
| Issue Date FY: 2019 ( Subtotal = $502,558 ) |
| | 2019 | 2019 | BIODESY, INC. | 170 HARBOR WAY STE 100 | SOUTH SAN FRANCISCO | CA | 94080-6102 | SAN MATEO | USA | R43MH119906 | SHG based screening assay for detecting effectors of brain localized GPCRs that can be used to probe mental illness related phenotypes | 002 | 1 | NIH | 7/13/2019 | $279,745 |
| | 2019 | 2019 | BIODESY, INC. | 170 HARBOR WAY STE 100 | SOUTH SAN FRANCISCO | CA | 94080-6102 | SAN MATEO | USA | R43MH119906 | SHG based screening assay for detecting effectors of brain localized GPCRs that can be used to probe mental illness related phenotypes | 000 | 1 | NIH | 5/10/2019 | $279,745 |
| | 2019 | 2019 | BIODESY, INC. | 170 HARBOR WAY STE 100 | SOUTH SAN FRANCISCO | CA | 94080-6102 | SAN MATEO | USA | R43MH119906 | SHG based screening assay for detecting effectors of brain localized GPCRs that can be used to probe mental illness related phenotypes | 001 | 1 | NIH | 7/9/2019 | -$279,745 |
| | 2019 | 2019 | BIODESY, INC. | 170 HARBOR WAY STE 100 | SOUTH SAN FRANCISCO | CA | 94080-6102 | SAN MATEO | USA | R43TR002783 | High-throughput screening assay of GPCR drug candidates using second harmonic generation for direct detection of structural changes | 000 | 1 | NIH | 7/9/2019 | $222,813 |
|
| Issue Date FY: 2006 ( Subtotal = $150,272 ) |
| | 2006 | 2006 | BIODESY LLC | 3960 BROADWAY | NEW YORK | NY | 10032 | NEW YORK | USA | R43CA125917 | SHG FOR INTEGRIN RECEPTOR DRUG DISCOVERY | 000 | 1 | NIH | 9/28/2006 | $150,272 |
|
| Issue Date FY: 2005 ( Subtotal = $100,000 ) |
| | 2005 | 2005 | BIODESY LLC | 3960 BROADWAY | NEW YORK | NY | 10032 | NEW YORK | USA | R43GM075439 | REAL-TIME DETECTION OF GPCR CONFORMATIONAL CHANGE | 000 | 1 | NIH | 8/9/2005 | $100,000 |
|
|
